Skip to main content
padlock icon - secure page this page is secure

Publisher: Wiley-Blackwell

Volume 70, Number 4, April 2003

Human platelets express hemochromatosis protein (HFE) and transferrin receptor 2
pp. 201-206(6)
Authors: Hannuksela, Jokke; Parkkila, Seppo; Waheed, Abdul; Britton, Robert S.; Fleming, Robert E.; Bacon, Bruce R.; Sly, William S.

Favourites:
ADD

Optical tweezers for measuring red blood cell elasticity: application to the study of drug response in sickle cell disease
pp. 207-211(5)
Authors: Brandão, M. M.; Fontes, A.; Barjas-Castro, M. L.; Barbosa, L. C.; Costa, F. F.; Cesar, C. L.; Saad, S. T. O.

Favourites:
ADD

Lymphoproliferative disease of granular lymphocytes with T-cell receptor gamma delta-positive phenotype: restricted usage of T-cell receptor gamma and delta subunit genes
pp. 212-218(7)
Authors: Makishima, Hideki; Ishida, Fumihiro; Saito, Hiroshi; Ichikawa, Naoaki; Ozaki, Yayoi; Ito, Susumu; Ota, Masao; Katsuyama, Yoshihiko; Kiyosawa, Kendo

Favourites:
ADD

Salvage treatment with etoposide (VP-16), ifosfamide and cytarabine (Ara-C) for patients with recurrent primary central nervous system lymphoma
pp. 219-224(6)
Authors: Arellano-Rodrigo, Eduardo; López-Guillermo, Armando; Bessell, Eric M.; Nomdedeu, Benet; Montserrat, Emili; Graus, Francesc

Favourites:
ADD

Influenza vaccine in chronic lymphoproliferative disorders and multiple myeloma
pp. 225-230(6)
Authors: Rapezzi, Davide; Sticchi, Laura; Racchi, Omar; Mangerini, Rosa; Ferraris, Anna Maria; Gaetani, Gian Franco

Favourites:
ADD

Squamous cutaneous epithelial cell carcinoma in two CML patients with progressive disease under imatinib treatment
pp. 231-234(4)
Authors: Baskaynak, Gökben; Kreuzer, Karl-Anton; Schwarz, Michaela; Zuber, Johannes; Audring, Heike; Riess, Hanno; Dörken, Bernd; le Coutre, Philipp

Favourites:
ADD

Double minutes containing amplified bcr-abl fusion gene in a case of chronic myeloid leukemia treated by imatinib
pp. 235-239(5)
Authors: Morel, Frédéric; Bris, Marie-Josée Le; Herry, Angèle; Calvez, Geneviève Le; Marion, Véronique; Abgrall, Jean-François; Berthou, Christian; Braekeleer, Marc De

Favourites:
ADD

Acute myeloid leukemia mimicking primary testicular neoplasm. Presentation of a case with review of literature
pp. 242-245(4)
Authors: McIlwain, Laura; Sokol, Lubomir; Moscinski, Lynn C.; Saba, Hussain I.

Favourites:
ADD

Acute myelogenous leukemia in an adult with thrombocytopenia with absent radii syndrome
pp. 246-248(3)
Authors: Go, Ronald S.; Johnston, Kaye L.

Favourites:
ADD

Signet ring-like light chain myeloma with systemic spread
pp. 249-250(2)
Authors: Haidar, Joud H.; Bazarbachi, Ali; Nasr, Michel R.; El-Sabban, Marwan E.; Daher, Rose

Favourites:
ADD
Favourites:
ADD

Requiem to prenatal diagnosis of haemophilia A and B using coagulation activity and antigen based assays: not yet!
pp. 253-254(2)
Authors: Shetty, Shrimati; Ghosh, Kanjaksha; Anbhavne, Shankar; Mohanty, Dipika

Favourites:
ADD
Favourites:
ADD

ABC of Clinical Haematology
pp. 256-256(1)
Author: Bjerrum, Ole Weis

Favourites:
ADD

A perspective on the measurement of ADAMTS13 in thrombotic thrombocytopaenic purpura
pp. 257-262(6)
Authors: Pimanda, John E.; Chesterman, Colin N.; Hogg, Philip J.

Favourites:
ADD

Thalidomide and IMiDs
pp. 263-263(1)
Author: Stirling, D.

Favourites:
ADD

The development of novel targeted therapeutics for treatment of multiple myeloma research roundtable
pp. 263-263(1)
Authors: Anderson, Kenneth C.; Barlogie, Bart; Berenson, James R.; Dalton, William S.; Adams, Julian; Alsina, Melissa; Bekker, Pirow; Bergsagel, Peter L.; Boise, Lawrence; Chan, Kyle; Chanan-Khan, Asher A.; Comenzo, Raymond; Congdon, Deborah; Croucher, Peter; Epstein, Joshua; Fenton, Robert; Fonseca, Rafael; Gallant, Gilles; Hussein, Mohamad A.; Jagannath, Sundar; Pearse, Roger N.; Roodman, David G.; Sausville, Edward; Shaughnessy, John D.; Stewart, Keith; Stirling, David I.; Trudel, Suzanne; Ness, Brian Van; Witzig, Thomas E.

Favourites:
ADD

Gene expression in arsenic trioxide-resistant multiple myeloma
pp. 265-265(1)
Authors: Comenzo, R.; Kalakonda, N.; Zhou, P.

Favourites:
ADD

Preclinical evaluation of arsenic trioxide in multiple myeloma
pp. 266-266(1)
Authors: Boise, L.; McCafferty, J.; Bahlis, N.; Lee, K.

Favourites:
ADD
Favourites:
ADD

Neovastat in multiple myeloma
pp. 267-268(2)
Authors: Jagannath, S.; Champagne, P.; Hariton, C.; Dupont, É.

Favourites:
ADD

Rational therapy targeting the initial genetic event in multiple myeloma: FGFR3 as a drug target in t(4;14) myeloma
pp. 268-268(1)
Authors: Trudel, S.; Ely, S.; Farooqui, Y.; Chesi, M.; Bergsagel, P.

Favourites:
ADD
Favourites:
ADD

Farnesyltransferase inhibitor FTI-R115777 is well tolerat ed, induces stabilization of disease, and inhibits farnesylation and oncogenic/tumor survival pathways in patients with advanced multiple myeloma
pp. 269-269(1)
Authors: Alsina, M.; Wilson,   E.; Belle, N.; Gerbino, E.; Overton, R.; Sullivan, D.; Djulbegovic, B.; Fonseca, R.; Dalton, W.; Sebti, S.

Favourites:
ADD
Favourites:
ADD

Targeting JNK and p27 to inhibit multiple myeloma cell growth
pp. 269-270(2)
Authors: Chan, K.; Boluro-Ajayi, M.; Corral, L.; Ennis, B.; Mercurio, F.; deParseval, L.; Payvandi, F.; Plantevin, V.; Smith, K.; Stein, B.; Xie, W.; Xu, W.

Favourites:
ADD

RANK-Fc in myeloma
pp. 271-271(1)
Author: Pearse, R.

Favourites:
ADD

Bisphosphonates in the treatment of myeloma bone disease
pp. 271-272(2)
Author: Croucher, P.

Favourites:
ADD

Blocking CCR1 or CCR5 inhibits both osteoclast formation and increased α1-integrin expression induced by MIP-1α
pp. 272-272(1)
Authors: Choi, J.; Oba, Y.; Jelinek, D.; Ehrlich, L.; Lee, W.; Roodman, D.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more